Author Topic: (AAN abst.) Higher efficacy therapies may have a disproportionately larger effect in younger PwMS  (Read 15 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8247
  • MS diagnosed 1980
  • Location: Pacific Northwest
Abstract of a presentation at the annual AAN conference (Philadelphia, May 4-10, 2019) entitled "Higher efficacy therapies appear to have a disproportionately larger effect in younger patients with multiple sclerosis" from researchers at the University of Colorado:


http://indexsmart.mirasmart.com/AAN2019/PDFfiles/AAN2019-004406.pdf
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
27 Views
Last post November 07, 2016, 03:50:53 pm
by agate
0 Replies
40 Views
Last post November 17, 2017, 09:11:56 pm
by agate
0 Replies
63 Views
Last post March 16, 2018, 11:51:28 am
by agate
0 Replies
38 Views
Last post May 04, 2018, 02:21:14 pm
by agate
2 Replies
62 Views
Last post September 08, 2019, 04:17:59 pm
by agate